- Home
- IMUX vs CVU Comparison
IMUX vs CVU Comparison
Compare IMUX & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- CVU
- Stock Information
- Founded
- IMUX 2016
- CVU 1980
- Country
- IMUX United States
- CVU United States
- Employees
- IMUX N/A
- CVU N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- CVU Military/Government/Technical
- Sector
- IMUX Health Care
- CVU Industrials
- Exchange
- IMUX Nasdaq
- CVU Nasdaq
- Market Cap
- IMUX 86.3M
- CVU 70.2M
- IPO Year
- IMUX N/A
- CVU N/A
- Fundamental
- Price
- IMUX $1.27
- CVU $3.95
- Analyst Decision
- IMUX Strong Buy
- CVU
- Analyst Count
- IMUX 6
- CVU 0
- Target Price
- IMUX $12.67
- CVU N/A
- AVG Volume (30 Days)
- IMUX 795.3K
- CVU 96.9K
- Earning Date
- IMUX 03-04-2025
- CVU 04-04-2025
- Dividend Yield
- IMUX N/A
- CVU N/A
- EPS Growth
- IMUX N/A
- CVU 86.98
- EPS
- IMUX N/A
- CVU 1.37
- Revenue
- IMUX N/A
- CVU $82,814,085.00
- Revenue This Year
- IMUX N/A
- CVU N/A
- Revenue Next Year
- IMUX N/A
- CVU N/A
- P/E Ratio
- IMUX N/A
- CVU $2.88
- Revenue Growth
- IMUX N/A
- CVU N/A
- 52 Week Low
- IMUX $0.92
- CVU $2.16
- 52 Week High
- IMUX $2.11
- CVU $5.85
- Technical
- Relative Strength Index (RSI)
- IMUX 72.48
- CVU 33.91
- Support Level
- IMUX $0.92
- CVU $4.00
- Resistance Level
- IMUX $1.15
- CVU $4.54
- Average True Range (ATR)
- IMUX 0.07
- CVU 0.32
- MACD
- IMUX 0.03
- CVU -0.13
- Stochastic Oscillator
- IMUX 74.47
- CVU 3.51
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.